Structure–activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding-Reference-Cited by-同舟云学术

Structure–activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding

Published:2009-10 Issue:19 Volume:19 Page:5594-5598
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Beausoleil Eric,Chauvignac Cédric,Taverne Thierry,Lacombe Sandrine,Pognante Laure,Leblond Bertrand,Pallares Diego,Oliveira Catherine De,Bachelot Florence,Carton Rachel,Peillon Hélène,Coutadeur Séverine,Picard Virginie,Lambeng Nathalie,Désiré Laurent,Schweighoffer Fabien

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference30 articles.

1. RNA and Disease

2. Differential Splicing, Disease and Drug Targets

3. Alternative splicing and disease

4. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and In Vitro Triglyceride-Lowering Activity of 2,3-Disubstituted Berberine Derivatives;HETEROCYCLES;2022

2. Rac1b: An emerging therapeutic target for chemoresistance in colorectal cancer;Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies;2020

3. RAC1B: A Rho GTPase with Versatile Functions in Malignant Transformation and Tumor Progression;Cells;2019-01-04

4. Targeting Rac and Cdc42 GTPases in Cancer;Cancer Research;2018-06-01

5. Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics;WIREs RNA;2018-04-25